Read + Share
Antoniotti C, Marmorino F, Boccaccino A, Martini S, et al. Early modulation of Angiopoietin-2 plasma levels predicts benefit from
regorafenib in patients with metastatic colorectal cancer. Eur J Cancer 2022;165:116-124.
PMID: 35231767
|
 |
|
Antoniotti C, Marmorino F, Boccaccino A, Martini S, et al. Early modulation of Angiopoietin-2 plasma levels predicts benefit from
regorafenib in patients with metastatic colorectal cancer. Eur J Cancer 2022;165:116-124.
PMID: 35231767
|
|
|
|